Sensipar recall (Amgen, Inc.)
DrugClass IIOngoing
Summary: Amgen, Inc. is recalling Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30. Reason: CGMP Deviations.
What is being recalled
Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30
Why
CGMP Deviations
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
Nationwide within the United States
How to tell if yours is affected
Lot #: 1157055, Exp. Date 1/31/2028
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0614-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | June 4, 2026 |
| Reported | July 1, 2026 |
| Company | Amgen, Inc. |
| Company location | Thousand Oaks, CA, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | N/A |
More recalls from Amgen, Inc. · all drug recalls · recalls from June 2026